| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 102/02/08 | 107/06/29 | 簡銘達 | 簡銘達 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -2.37(Q2) | 0 | 6.04 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 1,357,711,420 | 135,771,142 | ||
| 主要經營業務 | |||
| 新藥研發 | |||
| 公司網址 | |||
| foreseepharma.com | |||
逸達(6576) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 0 | 130 | -100% | -100% | 65,936 | 286,182 | -77% |
| 2023/07 | 43 | 12,407 | -99.9% | -99.7% | 65,936 | 286,052 | -76.9% |
| 2023/06 | 37,210 | 1,977 | 24706.7% | 1782.1% | 65,893 | 273,645 | -75.9% |
| 2023/05 | 150 | 42,371 | 18.1% | -99.6% | 28,683 | 271,668 | -89.4% |
| 2023/04 | 127 | 162,319 | -98.1% | -99.9% | 28,533 | 229,297 | -87.6% |
| 2023/03 | 6,666 | 66,634 | 3089.5% | -90% | 28,406 | 66,978 | -57.6% |
| 2023/02 | 209 | 106 | -99% | 97.2% | 21,740 | 344 | 6219.8% |
| 2023/01 | 21,531 | 238 | 130.7% | 8946.6% | 21,531 | 238 | 8946.6% |
| 2022/12 | 9,331 | 121 | 4542.3% | 7611.6% | 301,506 | 226,029 | 33.4% |
| 2022/11 | 201 | 197 | -10.3% | 2% | 292,175 | 225,908 | 29.3% |
| 2022/10 | 224 | 128 | -96% | 75% | 291,974 | 225,711 | 29.4% |
| 2022/09 | 5,568 | 17 | 4183.1% | 32652.9% | 291,750 | 225,583 | 29.3% |
| 2022/08 | 130 | 27 | -98.9% | 381.5% | 286,182 | 225,566 | 26.9% |
| 2022/07 | 12,407 | 67 | 527.6% | 18417.9% | 286,052 | 225,539 | 26.8% |
| 2022/06 | 1,977 | 46,956 | -95.3% | -95.8% | 273,645 | 225,472 | 21.4% |
| 2022/05 | 42,371 | 106,400 | -73.9% | -60.2% | 271,668 | 178,516 | 52.2% |
| 2022/04 | 162,319 | 92 | 143.6% | 176333.7% | 229,297 | 72,116 | 217.9% |
| 2022/03 | 66,634 | 71,811 | 62762.3% | -7.2% | 66,978 | 72,024 | -7% |
| 2022/02 | 106 | 143 | -55.5% | -25.9% | 344 | 213 | 61.5% |
| 2022/01 | 238 | 70 | 96.7% | 240% | 238 | 70 | 240% |
| 2021/12 | 121 | 194,801 | -38.6% | -99.9% | 226,029 | 230,439 | -1.9% |
| 2021/11 | 197 | 3 | 53.9% | 6466.7% | 225,908 | 35,638 | 533.9% |
| 2021/10 | 128 | 4 | 652.9% | 3100% | 225,711 | 35,635 | 533.4% |
| 2021/09 | 17 | 6 | -37% | 183.3% | 225,583 | 35,631 | 533.1% |
| 2021/08 | 27 | 717 | -59.7% | -96.2% | 225,566 | 35,625 | 533.2% |
| 2021/07 | 67 | 0 | -99.8% | 0% | 225,539 | 34,908 | 546.1% |
| 2021/06 | 46,956 | 0 | -55.9% | 0% | 225,472 | 34,908 | 545.9% |
| 2021/05 | 106,400 | 0 | 115552.2% | 0% | 178,516 | 34,908 | 411.4% |
| 2021/04 | 92 | 0 | -99.9% | 0% | 72,116 | 34,908 | 106.6% |
| 2021/03 | 71,811 | 26,611 | 50117.5% | 169.9% | 72,024 | 34,908 | 106.3% |
| 2021/02 | 143 | 5,770 | 104.3% | -97.5% | 213 | 8,297 | -97.4% |
| 2021/01 | 70 | 2,527 | -100% | -97.2% | 70 | 2,527 | -97.2% |
| 2020/12 | 194,801 | 2,240 | 6493267% | 8596.5% | 230,439 | 75,198 | 206.4% |
| 2020/11 | 3 | 2,133 | -25% | -99.8% | 35,638 | 72,958 | -51.2% |
| 2020/10 | 4 | 3,208 | -33.3% | -99.9% | 35,635 | 70,825 | -49.7% |
| 2020/09 | 6 | 0 | -99.2% | 0% | 35,631 | 67,617 | -47.3% |
永信建(5508) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 136.47% | 35.48% | 2020Q3 | 49.90% | 20.96% |
| 2023Q1 | -14.24% | -9.28% | 2020Q2 | 106.14% | 8.94% |
| 2022Q4 | -45.30% | -27.67% | 2020Q1 | -68.56% | -8.41% |
| 2022Q3 | 243.90% | 11.27% | 2019Q4 | 115.96% | 6.76% |
| 2022Q2 | -58.77% | -18.31% | 2019Q3 | 3.15% | -9.72% |
| 2022Q1 | -53.61% | 4.13% | 2019Q2 | -13.48% | -15.76% |
| 2021Q4 | 136.05% | 25.99% | 2019Q1 | -38.68% | -9.57% |
| 2021Q3 | -35.53% | 2.39% | 2018Q4 | 19.47% | 2.52% |
| 2021Q2 | 81.00% | 27.17% | 2018Q3 | -23.07% | -2.42% |
| 2021Q1 | -26.78% | 19.26% | 2018Q2 | 10.16% | -1.84% |
| 2020Q4 | 31.06% | 9.31% | 2018Q1 | 9.25% | 7.76% |
評論0